Drugs Made In America Acquisition DMIIU
NASDAQ DMIIU
$10.26 +0.03 (+0.29%)
As of: Nov 6, 2026 · 10:19 AM EST

Drugs Made In America Acquisition (DMIIU) Cash from Financing Activities (2026)

Updated

Drugs Made In America Acquisition (DMIIU) reported Cash from Financing Activities of $501 million for FY2025, compared with $211,334 in FY2024.

Analysis

Drugs Made In America Acquisition (DMIIU) Cash from Financing Activities (2026) Analysis & Trends

  • According to Business Quant data, Cash from Financing Activities came in at $211,334 in FY2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 450,000.00
API Access

Drugs Made In America Acquisition Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DMIIU&period=max&api_key=YOUR_API_KEY